In this study, we found that, in 2019, 66% of adults at a childbearing age and 83.4% of young infants before the age of the first dose of pertussis vaccination did not have detectable anti-PT IgG antibodies, showing that they were vulnerable to pertussis. The gene discussed is F2; the disease is pertussis.